SCHEMBL18103144

SCHEMBL18103144

CCO/C(=N\c1ccccc1OC)c1cccc(C(=O)Nc2ccccc2OC)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIRT2 Q8IXJ6 1/20 0.51
▸ MEN1 O00255 5/20 0.48
▸ KMT2A Q03164 5/20 0.48
▸ GRIN2D O15399 1/20 0.48
▸ GRIN3B O60391 1/20 0.48
▸ GRIN1 Q05586 1/20 0.48
▸ GRIN2A Q12879 1/20 0.48
▸ GRIN2B Q13224 1/20 0.48
▸ GRIN2C Q14957 1/20 0.48
▸ GRIN3A Q8TCU5 1/20 0.48
▸ SIGMAR1 Q99720 1/20 0.48
▸ MAPT P10636 2/20 0.48
▸ RXFP1 Q9HBX9 1/20 0.48
▸ NPC1 O15118 4/20 0.47
▸ RAB9A P51151 4/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ TSHR P16473 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18100388 0.94 MEN1 (0.50) SIRT2MEN1KMT2AMAPTRXFP1
SCHEMBL18103162 0.86 NOS3 (0.48) MEN1KMT2AGRIN2DGRIN3BGRIN1
SCHEMBL18100298 0.81 NOS3 (0.44) MEN1KMT2AGRIN2DGRIN3BGRIN1
SCHEMBL18103120 0.78 MEN1 (0.53) SIRT2MEN1KMT2AGRIN2DGRIN3B
SCHEMBL28241911 0.76 MEN1 (0.74) SIRT2MEN1KMT2AMAPTNPC1
SCHEMBL16681360 0.75 KMT2A (0.76) SIRT2MEN1KMT2AMAPTNPC1
SCHEMBL8970331 0.75 MAPT (0.65) SIRT2MEN1KMT2AMAPTNPC1
SCHEMBL6798428 0.73 MEN1 (0.83) SIRT2MEN1KMT2ARXFP1NPC1
SCHEMBL5831957 0.73 KMT2A (0.64) SIRT2MEN1KMT2AMAPTRXFP1
SCHEMBL13576585 0.73 PDE4D (0.76) MEN1KMT2AMAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160280851-A1 IMINOETHER COMPOUND, POLYESTER RESIN COMPOSITION, METHOD FOR PRODUCING CARBOXYLIC ACID ESTER, POLYESTER FILM, BACK SHEET FOR SOLAR CELL MODULE, AND SOLAR CELL MODULE FUJIFILM CORPORATION (JP) 2016-09-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160280851-A1 IMINOETHER COMPOUND, POLYESTER RESIN COMPOSITION, METHOD FOR PRODUCING CARBOXYLIC ACID ESTER, POLYESTER FILM, BACK SHEET FOR SOLAR CELL MODULE, AND SOLAR CELL MODULE BRS3, RAD1, RAD51 SIRT2 4658/4885MEN1 273/4885KMT2A 2801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback